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1. Introduction 
It is well known that malignant mesothelioma is caused by exposure to asbestos, which 
comprises a group of naturally occurring fibrous minerals. However, the mechanism by 
which asbestos causes malignant mesothelioma remains unclear. Many researchers have 
examined the effect of exposure to asbestos on the body. To date, it has been confirmed that 
asbestos can cause various forms of damage to cells, including cellular toxicity and 
mutagenicity, as well as produce reactive oxygen species (ROS) (Mossman & Churg, 1998; 
Mossman et al., 1996; Sporn & Roggli, 2004). The levels of oxidized pyrimidine and 
alkylated bases correlate with the period of occupational exposure to asbestos (Dusinska et 
al., 2004), and the increase in mutation frequency of lung DNA is caused by instillation of 
asbestos through the trachea (Topinka et al., 2004). All of these factors are thought to 
generate the tumorigenic effect of asbestos on mesothelial cells. However, the development 
of malignant mesothelioma caused by exposure to asbestos shows the noteworthy 
characteristics of this condition, which differ from those induced by other toxic materials. 
Malignant mesothelioma develops under a relatively low or medium dose of exposure to 
asbestos. A high dose of exposure to asbestos causes the development of pneumoconiosis, 
i.e., asbestosis rather than mesothelioma. Thus, the development of mesothelioma caused by 
exposure to asbestos cannot be explained only by a general rule regarding a dose-response 
relationship of toxic materials. In addition, it takes a long period of about forty years to 
develop malignant mesothelioma after exposure to asbestos. These findings suggest the 
existence of other factors related to the development of malignant mesothelioma that are 
modified by exposure to asbestos in the body, and which differ from the well-known 
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tumorigenic effect of asbestos on mesothelial cells. One possible factor seems to be the effect 
of exposure to asbestos on anti-tumor immunity. In the body, the development of tumors is 
protected by anti-tumor immunity, composed of various kinds of cells including dendritic 
cells (DC), natural killer (NK) cells, helper T (Th) cells, cytotoxic T lymphocytes (CTLs), and 
so on. Exposure to asbestos might cause a suppressive effect on anti-tumor immunity in 
addition to the tumorigenic effect on mesothelial cells, and the combination of immune-
suppressive and tumorigenic effects of asbestos might contribute to the development of 
malignant tumor (Fig. 1).  
 
Figure 1. Hypothesis concerning the development of malignant mesothelioma caused by the 
immunological and tumorigenic effects of asbestos exposure. Many researchers have attempted to 
examine the tumorigenic effect of asbestos, thought to cause malignant mesothelioma (left). We propose 
the hypothesis that immune-suppressive effects, including the effect on NK- and T-cell functions, and 
the tumorigenic effects of asbestos exposure might contribute to the development of malignant 
mesothelioma (right). 
The lung is not the only place where immune competent cells are able to meet asbestos 
fibers. Inhaled asbestos fibers reach the lung via the trachea, but they do not remain at that 
site. Those fibers translocate into the lung-draining lymph nodes over a long period. Dodson 
et al. examined the amount of asbestos in the lungs, lymph nodes, and plaque in a cohort of 
former shipyard workers, and reported that an analysis of asbestos in the lymph nodes 
confirmed accumulation in these sites (Dodson et al., 1991). In addition, asbestos fibers in 
the lymph nodes can translocate into the blood and may be observed in any tissue of the 
body, even in the brain where the accumulation of asbestos is low because of the blood-
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brain barrier (Miserocchi et al., 2008). Thus, immune competent cells have many 
opportunities to encounter asbestos fibers in the body, and the primary place where these 
cells meet asbestos seems to be the lung-draining lymph nodes (Fig. 2).  
 
Figure 2. Places where immune competent cells encounter asbestos. Inhaled asbestos fibers reach the 
lung and translocate into the lung-draining lymph nodes. Therefore, the primary places where immune 
cells encounter asbestos seem to be the lung-draining lymph nodes. 
 
Figure 3. Present problems in malignant mesothelioma and the demand for a new parameter useful in 
making a diagnosis of malignant mesothelioma. Due to the problems shown in the top box, more useful 
and easy parameters to detect malignant mesothelioma in people exposed to asbestos are needed, to 
which our investigation of asbestos-related immunological alteration might contribute. 
 Long incubation period after asbestos exposure 
 Short life expectancy of patients with mesothelioma 
 Difficulty in diagnosis for malignant mesothelioma 
 Less information for people positive for pleural plaque 
Demand for more useful and easy parameters to make a 
diagnosis of mesothelioma in people exposed to asbestos 
Investigation of asbestos-related immunological alteration 
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The present diagnosis for malignant mesothelioma is based on X-ray and CT image 
analyses, as well as pathohistological analysis. However, diagnosis using these procedures 
is sometimes accompanied with a risk of radiation exposure or invasiveness, and results are 
not regarded equally among doctors because they have learned these analyses separately 
and it is not easy to master all of these methods. In addition, although it takes a long period 
to develop malignant mesothelioma after exposure to asbestos, the mean life expectancy of 
patients with malignant mesothelioma is short, and people exposed to asbestos need a safer 
analysis that can be used frequently in a year in order to detect malignant mesothelioma as 
early as possible. Recently, the use of products derived from mesothelioma cells for 
diagnosis has been proposed, including megakaryocyte potentiating factor (MPF) and 
mesothelin (Creaney et al., 2007; Onda et al., 2006). However, those products might not be 
observed in the blood that early because they will appear exactly after the development of 
mesothelioma, and it may take some time for those products to transfer from the pleural 
cavity into the blood stream. Many people exposed to asbestos worry about the 
development of malignant mesothelioma; however, there is little predictive information 
regarding the onset of mesothelioma. Therefore, there is a need to find a new parameter or 
method useful for the early diagnosis of malignant mesothelioma (Fig. 3). If some 
characteristic alteration of immune function is caused by exposure to asbestos that is also 
found in patients with malignant mesothelioma, which can be measured by checking 
lymphocytes or other cells in peripheral blood, the analysis for that alteration might 
contribute to the early detection of malignant mesothelioma.    
On the basis of these ideas, we started to investigate the immunological effect of exposure to 
asbestos and immunological alteration in patients with malignant mesothelioma. In this 
chapter, we show the results obtained from these studies concerning the effect of asbestos 
on anti-tumor immunity, focusing on NK and Th cells, and discuss the immune-suppressive 
effect of asbestos and the possible application of our results for the early diagnosis of 
malignant mesothelioma. 
2. NK cells 
The role in cytotoxicity against target cells in anti-tumor immunity is played by two 
populations of cells, natural killer (NK) cells and cytotoxic T lymphocytes (CTLs). NK cells 
have a cytotoxicity for targets which they are ready to kill without prior stimulation, 
whereas this readiness is absent from the killing activity of CTLs and is induced by antigen 
stimulation. Therefore, although the cytotoxicity of NK cells has no antigen specificity, it is 
thought to contribute widely to the early deletion of unhealthy cells such as virus-infected 
cells or transformed cells. On the other hand, it takes time to induce the differentiation of 
naïve CD8+ T cells to CTLs, but they can recognize target cells precisely and injure them 
effectively. Imai et al. examined whether differences between individuals in regard to 
natural immunological host defense, i.e., NK cytotoxicity, can predict the future 
development of cancer. They reported that medium and high cytotoxic activity of peripheral 
blood lymphocytes is associated with reduced cancer risk, whereas low activity is associated 
with increased cancer risk, and these findings suggest a role for natural immunological host 
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defense mechanisms against cancer (Imai et al., 2000). Therefore, we examined the effect of 
exposure to asbestos on cytotoxicity of NK cells and alteration in cytotoxicity of NK cells in 
patients with malignant mesothelioma. 
2.1. Mechanism of cytotoxicity in NK cells 
The mechanism of cytotoxicity in NK cells and CTLs can be separated into two parts. The 
role of one part is to recognize target cells, which is followed by transduction of the 
stimulation signal into the cytosol, while the other part acts to kill target cells. In the killing 
mechanism, both NK cells and CTLs use the common molecules perforin and granzymes. 
Perforin- and granzyme-induced apoptosis is the main pathway used by cytotoxic 
lymphocytes to eliminate virus-infected or transformed cells (Trapani & Smyth, 2002). 
Perforin and granzymes are produced and accumulate in the cytotoxic granules of NK cells. 
Once NK cells are optimally stimulated, perforin and granzymes are released into the gap of 
the immune synapse by degranulation and act on target cells to induce apoptosis. Perforin is 
the protein that can disrupt the cellular membrane and create a pore in the membrane of the 
target cell. Granzyme is a family of structurally related serine proteases, which enters target 
cells through the pore made by perforin, and induces apoptosis of the target cells. The 
second pathway to kill targets is Fas-mediated apoptosis, induced by ligation of the Fas 
ligand (FasL) expressed on NK cells or CTLs with Fas on target cells. In addition to these 
two pathways, tumor-necrosis factor-related apoptosis-inducing ligand (TRAIL) is also 
known to control the growth and metastasis of tumors (Smyth et al., 2001; Takeda et al., 
2001). These killing mechanisms are followed by recognition of target cells by NK cells. In 
contrast to T cell, which utilizes the T cell receptor (TCR) to recognize targets, NK cells 
utilize various kinds of receptors for target recognition. These receptors could be of either 
type: inhibitory or activating. In the next section, we explain the significance of the 
expression levels of NK cell receptors for cytolytic activity.  
2.2. NK cell receptors 
NK cells do not have clonal diversity like T cells, which include many repertoires, 
rearrangements, and somatic mutations of TCRs. However, NK cells can recognize various 
target cells using various kinds of receptors expressed on the cell surface of NK cells 
(Moretta, L. & Moretta, A., 2004; Yokoyama & Plougastel, 2003). Some NK cell receptors, the 
ligands of which are human leukocyte antigen (HLA) molecules, genetically differing 
among individuals and recognized by T cells with T cell receptor (TCR) to find abnormal 
cells, have the role of transducing an inhibitory signal. Those inhibitory receptors include a 
KIR family of receptors and heterodimer of NKG2A and CD94. The inhibitory signals 
derived from those receptors contribute to prohibition of cytotoxicity against normal self 
cells. In contrast, several other receptors transduce an activation signal after ligation with 
their respective ligands to induce cytotoxicity against abnormal target cells (Fig. 4). NKG2D 
is the best characterized activating receptor expressed on NK cells. NKG2D is a receptor 
belonging to the same group as NKG2A, NKG2 family, characterized by a lectin-like 
domain, but can transduce an activation signal unlike NKG2A. The signaling lymphocytic 
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activation molecule (SLAM) family is another group of activating receptors expressed on 
NK cells. A representative receptor of the SLAM family is 2B4, which induces cytotoxicity 
by stimulation with the natural ligand, CD48, or the antibody to 2B4 (Endt et al., 2007; 
Garni-Wagner et al., 1993; Valiante & Trinchieri, 1993). Moreover, natural cytotoxicity 
receptors (NCRs) make a family of receptors that includes NKp46, NKp44 and NKp30, 
which play a major role in the NK-mediated killing of most tumor cells (Moretta, A. et al., 
2001; Sivori et al., 1999). These activating receptors transduce the stimulation signal leading 
to the phosphorylation of c-Jun N-terminal kinases (JNKs) and extracellular signal-regulated 
kinase (ERK), which cause polarization of the microtubule organizing center (MTOC) and 
cytotoxic granules followed by release of perforin and granzymes, producing degranulation 
(Chen et al., 2006; Chen et al., 2007). Thus, the various kinds of receptors expressed on NK 
cells control induction of cytotoxicity for target cells, and alteration in expression of these 
receptors is thought to affect the strength of the stimulation signal to induce cytotoxicity of 
NK cells. In addition, if NK cells exposed to asbestos show some characteristic alteration in 
expression of NK cell receptors, this alteration might be used as a possible marker of 
asbestos exposure-related immune alteration. Therefore, we planned to study the effect of 
asbestos exposure on NK cells, focusing on the expression level of NK cell receptors, as well 
as investigate the cytotoxicity of NK cells.  
 
Figure 4. NK cell-activating receptors and the machinery of degranulation caused by stimulation with 
these receptors. The ligation of NK cell-activating receptors with their respective ligands induce 
phosphorylation of JNK and ERK, leading to polarization of the microtubule organizing center (MTOC) 
and granules, where perforin and granzymes are released and induce apoptosis of target cells.  
2.3. Cytotoxicity of human NK cell line cultured with asbestos for a long period 
We initially started by making the sub-line of an NK cell line by culturing cells exposed to 
asbestos for a long period. The human NK cell line of YT-A1 was kindly provided by Dr. 
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Yodoi and was used for this experiment. Before starting the culture, the effect of exposure to 
chrysotile B (CB) on the survival and growth of YT-A1 cells was examined in order to avoid 
a high dose of exposure to CB which induces intense apoptosis and inhibition of cell growth. 
The apoptosis of YT-A1 was not induced upon exposure to CB at concentrations from 5 to 
100 µg/ml. However, cell growth was inhibited upon exposure to CB at a concentration 
greater than 50 µg/ml, whereas it was not inhibited below 20 µg/ml. Therefore, the dose of 
CB used was defined as 5 µg/ml, representing the concentration at which YT-A1 cells were 
cultured with CB, named YT-CB5, and the rest of cells was cultured in the original condition 
of media without CB, named YT-Org. The cultures were exposed for over five months and 
then periodically examined for the effect of asbestos exposure on the cytotoxicity of NK 
cells. The cells were assayed for cytotoxicity against K562 cells and expression levels of 
various kinds of NK cell receptors and other molecules using flow cytometry. There were no 
differences in cytotoxicity or expression levels of cell-surface molecules between YT-Org 
and YT-CB5 for one month after exposure to CB. However, after around 5 months of such 
exposure, YT-CB5 showed a clear decrease in cytotoxicity compared with YT-Org. In 
addition, decreases in expression levels of NKG2D and 2B4, but not of NKp46, were also 
found in YT-CB5 (Nishimura et al., 2009b). The expression level of CD56 and CD16, NK-cell 
marker and low-affinity Fc receptor, respectively, altered slightly. NKG2A, which makes a 
suppressive receptor with CD94, did not increase. In addition, YT-CB5 showed almost a 
zero level of granzyme A and exhibited a significant decrease in perforin, but the degree of 
decrease of perforin was not large and YT-CB5 did not show a significant decrease in 
granzyme B. Although 2B4 is not related to cytotoxicity against K562 cells in contrast to 
NKG2D and NKp46, YT-CB5 also showed the decrease in cytotoxicity against P815 cells 
treated with antibodies to 2B4, a cytotoxicity mediated by 2B4. These results supported the 
supposition that the decrease in NKG2D and 2B4 might cause impairment in induction of 
cytotoxicity by reducing signal transduction downstream of those receptors. Therefore, the 
degranulation stimulated by antibodies to NKG2D and 2B4 was examined in YT-CB5 by 
flow cytometry, which can estimate degranulation by measuring an increase in cell-surface 
CD107a accompanied with secretion of cytotoxic granules. YT-CB5 showed decreases in 
degranulation stimulated via NKG2D and 2B4, as observed under stimulation with bead-
bound and plate-bound antibodies, respectively. In addition, YT-CB5 also showed a 
decrease in phosphorylation of ERK1/2 stimulated with K562 cells as well as antibodies to 
NKG2D, but not with antibodies to 2B4 (Nishimura et al., 2009a). Moreover, we examined 
cytotoxicity against K562 cells, expression levels of NKG2D, 2B4 and NKp46, and the 
phosphorylation level of ERK1/2 stimulated with their respective antibodies in peripheral 
blood (PB-) NK cells purified from the blood of healthy volunteers, and compared results 
among the volunteers. PB-NK cells with a high expression of NKG2D, derived from one 
individual, showed high cytotoxicity and high phosphorylation of ERK1/2, whereas both 
cytotoxicity and ERK phosphorylation were low in PB-NK cells with low NKG2D, derived 
from another individual. In a similar way, the relationship among the cell-surface level of 
NKp46, phosphorylation level of ERK1/2, and cytotoxicity was also investigated and 
confirmed in PB-NK cells of healthy volunteers. Thus, we demonstrated that exposure to 
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asbestos caused an impairment in cytotoxicity of NK cells with decreases in NK cell-
activating receptors. The decrease in NKG2D caused the low level of signal transduction, 
followed by a decrease in degranulation, in the asbestos-exposed subline of cells.  
2.4. Low cytotoxicity and low NKp46 level in NK cells of mesothelioma patients 
The result of the experiment using the human NK cell line described above suggested that 
inhaled asbestos might cause impairment in cytotoxicity with altered expression of NK cell-
activating receptors, and that PB-NK cells in patients with malignant mesothelioma might 
show a similar impairment in cytotoxicity to YT-CB cells. Therefore, peripheral blood 
mononuclear cells (PBMCs) prepared from the blood of patients with mesothelioma were 
examined for cytotoxicity against K562 cells and expression levels of NKG2D, 2B4, and 
NKp46 in NK cells. The cytotoxicity of PBMCs against K562 in the tree different ratios of 
effector and targets was measured for each individual, and expressed as the percentage of 
specific lysis. To evaluate cytotoxicity per given number of NK cells, The number of NK 
cells in the cytotoxic reaction was calculated from the percentage of CD3-CD56+ NK cells in 
PBMCs and the number of PBMCs dispensed to each well of the culture plate for cytotoxic 
reaction. A linear regression line with the percentage of specific lysis and number of NK 
cells, in which the formula is [percentage of specific lysis] = A [number of NK cells] + B, was 
determined by using the three sets of percentage of specific lysis and number of NK cells for 
each individual. Finally, the percentages of specific lysis per 5000 NK cells from each 
individual were calculated from these regression lines and compared with those of healthy 
volunteers. Mesothelioma patients showed significantly lower cytotoxicity than healthy 
volunteers (Nishimura et al., 2009b). However, unlike YT-CB5, NK cells in patients with 
mesothelioma did not show a decrease in expression level of NKG2D or 2B4, whereas a 
decrease in NKp46 was observed in those NK cells. Thus, although NK cells in the 
peripheral blood of patients with malignant mesothelioma were not of the same character as 
YT-CB5, they also showed alteration in the expression of one of the NK-cell activating 
receptors, albeit a different one namely NKp46, with low expression of NKp46, and low 
cytotoxicity. 
2.5. Low cytotoxicity of NK cells with low NKp46 in the culture of PBMCs with 
asbestos 
As described above, NK cells in patients with malignant mesothelioma showed low 
cytotoxicity with low expression of NKp46, which was not found in YT-CB5. Therefore, to 
examine whether asbestos exposure causes such a decrease in NKp46 on NK cells, we 
performed a different experiment in which PBMCs from healthy volunteers were cultured 
in IL-2-supplemented media with chrysotile B at 5 µg/ml, and after 7 days cells were 
harvested and examined for expression levels of NKG2D, 2B4, and NKp46 in CD3-CD56+ 
NK cells by flow cytometry. IL-2 is a representative cytokine that induces proliferation and 
activation of NK cells and is commonly used to culture these cells. The results showed no 
decreases in cell-surface expression of NKG2D and 2B4 in NK cells derived from the culture 
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with CB, whereas the expression of NKp46 decreased in those NK cells, resembling NK cells 
of patients with malignant mesothelioma (Nishimura et al., 2009b). To determine whether 
such restrictive alteration in expression of NK cell-activating receptors is caused by 
exposure to other mineral fibers, PBMCs were cultured with glass wool and then examined 
for the expression level of NKp46 on NK cells. Glass wool is a kind of man-made mineral 
fiber and is used as a representative substitute for asbestos. However, unlike asbestos, 
exposure to glass wool did not cause a decrease in expression of NKp46. These results 
indicate that exposure to asbestos causes the characteristic abnormality in human primary 
NK cells, resulting in a decrease in NKp46 but not in NKG2D. As described above, this 
characteristic is similar to that of PB-NK cells in patients with malignant mesothelioma, 
suggesting the possible relationship between asbestos exposure-related suppression of NK 
cell function and development of malignant mesothelioma.  
3. CD4+ T cells 
What is the function of CD4+ T cells in regard to an appropriate immune response? CD4+ T 
cells, Th, contribute to various kinds of responses in innate and acquired immunity, 
including activation of NK cells, macrophages and dendritic cells (DC), as well as induction 
of antibody production and CTL development (Monney et al., 2002; Parker, 1993; Smith et 
al., 2004; Vivier et al., 2008). The production of various cytokines, including IL-2, IL-4, IL-5, 
IL-10, IL-17, IFN-γ, and TNF-α, by Th cells is one of the reasons for the multiple 
contributions of those cells to immune function (Fig. 5).  
 
Figure 5. Cytokine-mediated control of immune functions and chemokine-mediated control of cell 
migration. The various kinds of cytokines produced by Th cells allow them to contribute widely to 
functions of immune competent cells (top). Concentration gradient of chemokines and expression of 
chemokine receptors play a key role in appropriate cell migration (bottom). 
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In addition, cytokines produced by Th cells can be transported by the blood stream, which 
allows them to exert an influence on distant cells as well as adjacent cells. Moreover, 
immune competent cells can migrate widely throughout the body, and Th cells are no 
exception to this rule. Chemokines, a group of cytokines, play a large role in such cell 
migration. For example, a chemokine produced in the periphery creates a concentration 
gradient, by which cells having the receptor for that chemokine can be attracted. Th cell 
migration is also controlled in a similar manner, in which the expression of receptors for 
chemokines influences the migration. As described below, our study discovered that the 
immunological effect of asbestos exposure involved a characteristic alteration in cytokine 
production and expression of chemokine receptor in Th cells chronically exposed to 
asbestos, and that Th cells in patients with malignant mesothelioma exhibited characteristics 
similar to those of asbestos-exposed cells. Before elaborating on these findings, in the next 
section we will detail the cytokines produced by Th cells and the Th cell migration 
controlled by chemokines and chemokine receptors.  
3.1. Cytokines produced by Th cells and polarization to Th1, Th2, Treg and Th17 
cells 
Antigen stimulation, made by a complex of MHC class II and antigen peptide, allows naïve 
Th cells to proliferate and produce cytokines. Th cells produce various kinds of cytokines, 
which can be classified according to the role they have in immune functions. TNF-α and 
IFN-γ stimulate activation of NK cells and exert a promoting effect on the development of 
CTL, by which they support cell-mediated immunity for elimination of virus-infected or 
transformed/tumor cells. In contrast, IL-4 supports humoral immunity, in which it 
stimulates production of immunoglobulin, in particular IgE, by plasma cells differentiated 
from B cells, and is related to allergy and asthma. In addition, IFN-γ and IL-4 produced by 
Th cells show a mutual suppression in each other’s production. As a result of such 
suppression, Th cells dominantly producing IFN-γ show less production of IL-4 and vice 
versa. Therefore, such development of Th cells exhibits a dominant production of 
cytokinesis, called “polarization”, and the cells showing dominant production of IFN-γ and 
IL-4 are Th1 and Th2 cells, respectively (Liew, 2002). Moreover, part of the Th cells 
differentiate to regulatory T (Treg) cells, which dominantly produce IL-10 and TGF-β, 
immune-suppressive cytokines, and play a role in regulation of the immune response 
(Asseman et al., 1999; Dieckmann et al., 2002; Green et al., 2003; Jonuleit et al., 2002), 
although a part of Treg occurs naturally without antigen stimulation (Sakaguchi, 2005). It 
has also been reported that Th cells producing IL-17, called Th17, contribute to autoimmune 
diseases (Peck & Mellins, 2009). Thus, several cytokines produced by Th cells and 
subpopulations of polarized Th cells show a characteristic role in immune functions. 
Therefore, immune status can be estimated by examining the production of these cytokines.   
3.2. Chemokine receptors expressed on Th cells 
Although immune competent cells are spread over the body, they must move to the place 
where they are needed according to their functions, and this also applies to each 
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subpopulation of Th cells. Naïve T cells, both CD4+ and CD8+ cells, have to reach secondary 
lymphoid organs to check an antigen processed by antigen-presenting cells. In contrast, Th1 
and Th2 cells, as effector cells, move to the periphery where they must encounter 
appropriate partners. Therefore, the expression of receptors for chemokines differs among 
the subpopulations of Th cells (Sallusto & Lanzavecchia, 2000). Naïve T cells express the 
chemokine receptor CCR7, by which they acquire responsiveness to its ligands SLC and 
ELC and can move to secondary lymphoid organs. In contrast, Th1 and Th2 cells lose the 
expression of CCR7 and acquire the expression of CXCR3 and CCR5 or CCR3 and CCR4, 
respectively, although these expressions are a little flexible. CXCR3 is expressed on some 
NK cells, and CXCL10, the ligand of CXCR3, accumulates NK cells in tumors (Qin et al., 
1998; Wendel et al., 2008). In addition, mice deficient for CXCL10 show impairment in T cell 
proliferation, IFN-γ production, contact hyper-sensitivity, a representative Th1 response, 
and recruitment of CD4+ and CD8+ cells in the periphery (Dufour et al., 2002). On the other 
hand, CCR3 is expressed at high levels on eosinophils, basophils, and mast cells, the 
population of cells related to allergy and asthma (Gerber et al., 1997). Thus, the 
subpopulations of Th cells differ in the expression of chemokine receptors, which is related 
to their different roles in immune functions, and the assay for expression of chemokine 
receptors on Th cells allows us to obtain information regarding the balance of the Th1/Th2 
response as well as cell migration.  
3.3. Impaired Th1 function of the human T cell line continuously exposed to 
asbestos 
As described above, many immune functions are under the control of Th cells. Therefore, we 
examined the effect of asbestos exposure on Th cells. At the beginning of this study, we 
prepared an in vitro T-cell model of long-term and low-level exposure to chrysotile asbestos 
using MT-2 cells, a human adult T-cell leukemia virus (HTLV)-1-immortalized human 
polyclonal cell line, resulting in six sublines exposed to asbestos. These sublines were 
established from the independent cultures of MT-2 cells with chrysotile asbestos. All of the 
sublines acquired resistance to asbestos-induced apoptosis after more than eight months of 
continuous exposure, and were named MT-2Rsts. Those six MT-2Rsts were used for DNA 
microarray analysis, compared with the original MT-2 cells, named MT-2Org. The analysis 
clarified statistically significant alterations in expression of 139 genes in MT-2Rsts, greater 
than twofold changes. To identify genes related to the suppression of anti-tumor immunity, 
the expression data were processed by the MetaCore Analytical Suite 
(http://www.genego.com; GeneGo, St. Joseph, MI) to search for deregulated networks and 
pathways. The results obtained from pathway and network analysis showed down-
regulation of IFN-γ signalling and CXCR3 expression in MT-2Rsts. As mentioned above, 
both IFN-γ and CXCR3 are related to Th1 cells. Therefore, we focused on Th1 functions of 
MT-2Rsts. All MT-2Rsts showed reduction of cell-surface expression of CXCR3, the mRNA 
level of which also decreased in MT-2Rsts, as assayed by real-time PCR. In addition, MT-
2Rsts showed a decrease in production of IFN-γ compared to MT-2Org, as assayed by 
ELISA. Moreover, the production of CXCL10 also decreased in MT-2Rsts (Maeda et al., 
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2010). These results indicate that continuous exposure of a human T cell line to asbestos 
impaired Th1 function, leading to decreases in cell-surface expression of CXCR3 and 
production of IFN-γ and CXCL10.  
3.4. Decreases in CXCR3 and IFN-γ in primary CD4+ T cells exposed to asbestos 
Following the results obtained from the experiment using the MT-2 cell line, we examined 
the effect of asbestos exposure on human primary CD4+ T cells (Maeda et al., 2011). CD4+ T 
cells freshly isolated from PBMCs were stimulated with antibodies to CD3 and CD28 and 
cultured in IL-2-supplemented media for 3 days, and the activated CD4+ T cells were 
transferred into a new culture plate and cultured with IL-2 for a week. These polyclonally 
expanded CD4+ T cells were used for culture with chrysotile B asbestos. After 40 days of 
culture, cell surface CXCR3 expression decreased in a dose-dependent manner. In contrast, 
the expression of CCR5 varied among all healthy volunteers, and there were no significant 
changes after culture with chrysotile. In addition, we examined intracellular expression and 
the mRNA level of IFN-γ in CD4+ T cells exposed to chrysotile B by flow cytometry and real-
time PCR. The CD4+ T cells exposed to chrysotile B showed a decrease in IFN-γ mRNA 
level, for which there was no significant difference, whereas IFN-γ positive cells tended to 
be reduced in those asbestos-exposed cells. These results indicate that chronic exposure to 
asbestos caused the decrease in CXCR3 and IFN-γ in CD4+ T cells, in accordance with results 
obtained from the experiment using the cell line.   
3.5. Decrease in CD4+CXCR3+ T cells in patients with mesothelioma 
Finally, we determined whether CD4+ T cells in asbestos-exposed patients showed the same 
impairment as shown by MT-2Rst sublines and in vitro asbestos-exposed primary CD4+ T 
cells (Maeda et al., 2011). Individuals positive for pleural plaque and patients with 
malignant mesothelioma were examined for CXCR3 expression and IFN-γ production in 
peripheral blood CD4+ T cells. Both plaque-positive individuals and mesothelioma patients 
showed a significantly lower percentage of CXCR3+ cells in CD4+ T cells than healthy 
volunteers. In addition, the percentages of CD4+ CXCR3+ T cells in lymphocytes from the 
plaque and mesothelioma groups were also significantly lower than those of the healthy 
group, and the mesothelioma group showed the lowest percentage among the three groups. 
In contrast to CXCR3, the percentage of CCR5+ cells in CD4+ T cells and CD4+ CCR5+ T cells 
in lymphocytes was not low in the plaque and mesothelioma groups. To examine 
production of IFN-γ by CD4+ T cells from plaque-positive individuals and mesothelioma 
patients, CD4+ T cells were stimulated with antibodies to CD3 and CD28, and cells and 
culture supernatants were harvested and assayed for mRNA and secreted levels of IFN-γ. 
The CD4+ T cells of mesothelioma patients showed a significantly lower mRNA level of IFN-
γ than that of plaque-positive individuals or healthy volunteers, whereas the secreted level 
of IFN-γ did not differ among the three groups. In addition, the concentration of CXCL10 in 
plasma tended to be higher for the plaque and mesothelioma groups than the healthy 
group, although there were no significant differences. CXCL10 can be produced by a variety 
of cells including endothelial cells, fibroblasts and monocytes near a cancerous lesion, to 
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attract anti-tumor T cells (Luster & Ravetch, 1987; Dufour et al., 2002; Homey et al., 2002). 
Moreover, the mesothelioma group showed a tendency for an inverse correlation between 
the percentage of CD4+CXCR3+ T cells and CXCL10 concentration, in comparison with the 
plaque and healthy groups. These results indicate that anti-tumor immune function in 
mesothelioma patients may be in the situation with less recruitment of Th1 cells using 
CXCR3, although the level of its ligand, CXCL10, is high.  
4. Conclusion and discussion 
We examined the effect of asbestos exposure on NK-cell and Th-cell functions using human 
NK- and T-cell lines continuously exposed to asbestos, primary cell cultures with asbestos, 
and analyses for peripheral blood NK and Th cells in plaque-positive individuals and 
patients with malignant mesothelioma. The results obtained from these studies indicate 
that asbestos exposure causes functional alterations in NK and Th cells, decreases in 
cytotoxicity and expression of NKG2D or NKp46, and decreases in production of IFN-γ 
and expression of CXCR3, respectively. It is known that NK cell-activating receptors 
transduce a signal to induce phosphorylation of ERK and JNK, causing degranulation of 
cytotoxic granules. The results of our study also showed the relationship between the 
expression level of NKG2D or NKp46, ERK phosphorylation, and cytotoxicity using the 
NK cell line and peripheral blood NK cells from healthy individuals. Therefore, the 
asbestos-induced decrease in expression of NKG2D or NKp46 is thought to cause 
impairment of NK cell-mediated anti-tumor immunity. In addition, IFN-γ is a key cytokine 
for the Th1 response and CXCR3 is one of the representative chemokine receptors 
expressed on Th1 cells. Therefore, the asbestos-induced decrease of IFN-γ and CXCR3 in 
Th cells indicates the decrease of the Th1 response, which contributes to impairment of the 
immune response to tumors. These findings concerning NK and Th cells indicate that 
asbestos fibers have the potential to cause impairment of anti-tumor immunity. This is the 
first demonstration that asbestos exerts an immune suppressive effect, as well as a 
tumorigenic effect. The immune-suppressive effect of asbestos might contribute to 
development of malignant mesothelioma in people exposed to asbestos. As described in 
the introduction, asbestos is known to accumulate in the lung-draining lymph nodes, as 
well as the lungs, where NK and Th cells might be exposed to asbestos. Furthermore, the 
results of our studies indicate that several kinds of functional impairment in NK and Th 
cells observed in experiments of in vitro or ex vivo exposure to asbestos can also be 
observed in the cells of patients with malignant mesothelioma, although the results include 
some inconsistencies. NK cells in patients with mesothelioma showed the same decrease in 
NKp46 as NK cells in the PBMC culture with chrysotile asbestos, and Th cells in plaque-
positive individuals and mesothelioma patients showed the same decrease in CXCR3 as the 
Th cell line and primary Th cells continuously cultured with chrysotile. In addition, it is 
noteworthy that there is also the consistency of parameters showing no alteration in 
expression between data from patients and cultures of primary cells. Those parameters are 
NKG2D and 2B4 for NK cells and CCR5 for Th cells, the altered expressions of which were 
not found in primary cells either exposed to asbestos or derived from patients with 
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mesothelioma. These findings suggest that those characteristic functional alterations of NK 
and Th cells shown in patients with malignant mesothelioma might be caused by inhaled 
and accumulated asbestos in the body. Furthermore, they also suggest the possibility that 
decreases in NKp46 on NK cells and CXCR3 on Th cells might contribute to early diagnosis 
of malignant mesothelioma as markers to monitor asbestos-related immune suppression. 
Today, the diagnosis of malignant mesothelioma is dependent on X-ray and CT image 
analyses, as well as pathohistological analysis, but these procedures involve several 
problems such as difficulty in obtaining a consistent diagnosis and a risk of radiation 
exposure or invasiveness. In contrast, the drawing of blood necessary for analysis of 
immunological markers is safe and easy, and can be performed frequently during a year. 
Therefore, imaging and pathohistological analyses of malignant mesothelioma combined 
with immunological analysis for expression of NKp46 and CXCR3 might provide more 
valuable information for people who are exposed to asbestos and worry about the 
development of malignant mesothelioma. Further studies regarding the immunological 
effect of asbestos exposure will contribute to the effective diagnosis and therapy of 
malignant mesothelioma. 
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